Skip to nav Skip to content
Multimedia

CDC/IDSA COVID-19 Clinician Call: New Monoclonal Antibody EUA, New Data on Treatment Dispensing and More Vaccine Q&A

To Download a copy of the presentation click here.

To Download a copy of the Q&A Responses click here.

*This call was funded by a cooperative agreement with the Centers for Disease Control and Prevention (grant number 6 NU50CK000477-04-01). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this call does not necessarily represent the policy of CDC or HHS, and should not be considered an endorsement by the Federal Government.

These one-hour webinars, held Saturdays at 3 p.m. ET, focus on timely issues of relevance to clinicians and feature case presentations by experts in the field, synthesis of new data, and an opportunity to engage with colleagues. Register for next week here.

Moderator:

Dana S. Wollins, DrPH, MGC
Vice President, Clinical Affairs & Practice Guidelines, IDSA


Topics and Featured Experts:

Assessment of Outpatient Dispensing of Products Proposed for Treatment or Prevention of COVID-19 by U.S. Retail Pharmacies During the Pandemic

  • CDR Jennifer N. Lind, PharmD, MPH
    Lead, Adverse Event Monitoring Unit
    CDC COVID-19 Health Systems and Worker Safety Task Force
  • CAPT Daniel Budnitz, MD, MPH
    Director, Medication Safety Program
    Division of Healthcare Quality Promotion, CD

New Monoclonal Antibody EUA

  • Wendy Carter, DO
    Lead Medical Officer of the Division of Antivirals
    US Food and Drug Administration
  • Patrizia Cavazzoni, MD
    Acting Director of the Center for Drug Evaluation and Research
    US Food and Drug Administration
  • Debra Birnkrant, MD
    Director of the Division of Antivirals
    US Food and Drug Administration
  • Natalie Pica, MD, PhD
    Medical Officer of the Division of Antivirals
    US Food and Drug Administration
  • John Farley, MD, MPH
    Director of the Office of Infectious Diseases
    US Food and Drug Administration
  • Adam Sherwat, MD
    Deputy Director of the Office of Infectious Diseases
    US Food and Drug Administration

More COVID-19 Vaccine Q&A

  • Sara Oliver, MD
    LCDR, U.S. Public Health Service
    Co-Lead, COVID-19 Work Group of the Advisory Committee on Immunization Practices
    Centers for Disease Control and Prevention
Details
Call / Meeting
Treatment
Advertisement